SLC5A2 and hydrops fetalis: Interestingly, the study by Avula et al. [16] extended these findings to patients with established CTRCD or HF, demonstrating that SGLT2 inhibitors reduced not only HF exacerbations but also atrial fibrillation and acute kidney injury.